- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03968068
Exercise and RIC and TCD
The Effects of Acute Exercise and Remote Ischaemic Conditioning (RIC) on Cerebral Blood Flow Velocity in Patients With Ischaemic Stroke and Healthy Controls
The first week after a stroke is a particularly important time, as improving blood flow may limit secondary ischaemic damage to the brain and help reduce the overall burden neurological injury and future disability.
Small studies in patients with stroke have shown that moderate aerobic exercise increases blood flow to the brain, however, no studies have evaluated the safety of aerobic exercise within the first week after stroke, nor whether it results in changes to cerebral blood flow.
Remote ischaemic conditioning (RIC) is when ischaemia is induced to a limb for short periods of time by inflating pressure cuffs around arms or legs to above systolic pressures (mmHg). This procedure is performed for periods that avoid physical injury to the limbs, but induce neurohormonal, systemic or vascular changes in the body. These changes often result in improved blood supply to various areas of the body. The use of RIC in the acute period after stroke is currently being investigated in a number of large randomised controlled trials e.g. RECAST, RESIST, however, our understanding of how RIC actually works is incomplete. Importantly, there is scarce data on the acute effects of RIC on cerebral blood flow (CBF), a potentially pivotal mechanism behind its effects.
We propose an exploratory study to evaluate whether it is feasible, acceptable and safe to undertake low and moderate intensity aerobic exercise or remote ischaemic conditioning (RIC) in patients during the acute period after stroke, and whether either of these interventions result in changes to cerebral blood flow velocity (CBFv) in the major cerebral arteries. We will compare any changes to those in a cohort of healthy volunteers.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Alisha Patel, MSc
- Phone Number: 0114 276 5394
- Email: alisha.patel@sth.nhs.uk
Study Locations
-
-
-
Sheffield, United Kingdom
- Sheffield Teaching Hospitals NHS FT
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adult (age > 18) patients who have suffered acute ischaemic stroke between 2-7 days previously, or healthy adult (>18 years).
- Ability to provide written informed consent
- Ability to mobilise lower body limbs (at least one leg)
- Ability to comply with study procedures in the opinion of the treating physician.
Exclusion Criteria:
- Haemorrhagic Stroke
- Ischaemic stroke < 2 days or >10 days
- Disability preventing lower extremity cycling
- New York Heart Failure Classification stage III/IV
- History of ischaemic stroke
- Current diagnosis of cancer
- Resting Blood pressure > 180 / 100 mmHg
- Clinically unstable
- History or presence of significant peripheral vascular disease in the upper limbs.
- History or presence of complex neuropathic pains or peripheral neuropathy in the arms.
- Presence of lymphoedema in the arms.
- Presence of skin ulceration to the arms.
- Uncontrolled arrhythmia, hypertension, diabetes or angina.
- Acute deep vein thrombosis, pulmonary embolism or pulmonary infection.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Exercise
|
Patients will undergo 30 minutes of light-moderate intensity leg cycling, using the Letto-2 (Motomed, UK) in the semi-supine position.
|
Experimental: Remote Ischaemic Conditioning
|
Patients will undergo 4 cycles of upper limb RIC using a blood pressure cuff.
Each cycle will involve inflating the blood pressure cuff to 200 mmHg for five minutes around the upper arm, followed by a period of relaxation of the cuff for a further 5 minutes.
The total RIC treatment time will take 40 minutes.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Incidences of RICTreatment-Emergent Adverse Events.
Time Frame: 48 hours
|
Safety of the RIC intervention will be assessed by measuring the Number of Adverse Events experienced by participants that are related to the RIC intervention.
|
48 hours
|
Number of Incidences of Exercise Treatment-Emergent Adverse Events.
Time Frame: 48 hours
|
Safety of the exercise intervention will be assessed by measuring the Number of Adverse Events experienced by participants that are related to the exercise intervention.
|
48 hours
|
Number of participants reporting RIC associated discomfort on a likert scale
Time Frame: 48 hours
|
Reported grade of discomfort associated with RIC will be measured on a likert scale of 0-5, 1 being very uncomfortable to 5 being very comfortable.
Acceptance of RIC will be defined as an average score of >3/5 on the likert scale.
|
48 hours
|
Number of participants reporting exercise associated discomfort on a likert scale
Time Frame: 48 hours
|
Reported grade of discomfort associated with exercise will be measured on a likert scale of 0-5, 1 being very uncomfortable to 5 being very comfortable.
Acceptance of exercise will be defined as an average score of >3/5 on the likert scale.
|
48 hours
|
% of RIC intervention completed and recorded
Time Frame: 48 hours
|
Feasibility of RIC will be defined as >80% of the intervention being completed and recorded.
|
48 hours
|
% of exercise intervention completed and recorded
Time Frame: 48 hours
|
Feasibility of exercise will be defined as >80% of the intervention being completed and recorded.
|
48 hours
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change from baseline in cerebral blood flow velocity.
Time Frame: 48 hours
|
Cerebral blood flow velocity will be measured using Transcranial Doppler (TCD).
|
48 hours
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Ali Ali, MD, Sheffield Teaching Hospitals NHS Foundation Trust
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Estimated)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STH20750
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke, Acute
-
University of CalgaryThe George Institute for Global Health, AustraliaNot yet recruitingAcute Ischemic Stroke AIS | Stroke, Acute, Stroke Ischemic | Stroke AcuteCanada, Australia
-
Cidat, S.A. de C.V.El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco SuarezUnknownStroke | Stroke, Acute | Cerebral Stroke | Cerebrovascular Stroke | Cerebrovascular Accident, AcuteMexico
-
Centre hospitalier de l'Université de Montréal...Not yet recruitingStroke, Acute ThromboticCanada
-
University of MiamiTemporarily not availableStroke, Ischemic | Stroke, Acute | Mesenchymal Stem Cells | Acute Ischemic Stroke | Stroke/Brain AttackUnited States
-
University Hospital, MontpellierNot yet recruiting
-
Capital Medical UniversityRecruitingAcute Stroke | Ischemic Stroke, AcuteChina
-
Chonbuk National University HospitalKorean Society of Neurosonology; Ministry of SMEs and Startups, Republic of... and other collaboratorsCompleted
-
Dongzhimen Hospital, BeijingThe Second Hospital of Hebei Medical University; Peking University Third Hospital and other collaboratorsRecruitingStroke, Ischemic | Stroke, Acute | Acute Ischemic StrokeChina
-
National Taiwan University HospitalCompleted
-
University of EdinburghNHS LothianRecruiting
Clinical Trials on Exercise Procedure
-
University Hospital, LilleRecruiting
-
William J. HanneyAdventHealth; Nova Southeastern University; Franklin Pierce UniversityCompletedNeck PainUnited States
-
Northwestern Health Sciences UniversityHealth Resources and Services Administration (HRSA); Berman Center for Outcomes...Completed
-
Northwestern Health Sciences UniversityHealth Resources and Services Administration (HRSA); Berman Center for Outcomes...Completed
-
Montclair State UniversityNational Cancer Institute (NCI)UnknownUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)TerminatedDepression | Fatigue | Rectal Cancer | Colon Cancer | Anxiety DisorderUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)Active, not recruitingMalignant Solid Neoplasm | Gastric Carcinoma | Pancreatic Carcinoma | Adult Liver CarcinomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)UnknownHematopoietic and Lymphoid Cell NeoplasmUnited States
-
Mayo ClinicCompletedHealthyUnited States
-
NYU Langone HealthCompleted